Efficacy and safety of Dapagliflozin add-on therapy to Evogliptin plus Metformin combinations in inadequately controlled patients with type 2 diabetes: A 24-week, Randomized, Double-blind, Placebo-con

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.